These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8589139)
21. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064 [TBL] [Abstract][Full Text] [Related]
22. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Mofenson LM; Korelitz J; Meyer WA; Bethel J; Rich K; Pahwa S; Moye J; Nugent R; Read J J Infect Dis; 1997 May; 175(5):1029-38. PubMed ID: 9129063 [TBL] [Abstract][Full Text] [Related]
23. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients. Crow ME Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115 [TBL] [Abstract][Full Text] [Related]
24. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145 [TBL] [Abstract][Full Text] [Related]
25. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796 [TBL] [Abstract][Full Text] [Related]
26. Sinusitis in HIV-infected patients: a clinical and radiographic review. Godofsky EW; Zinreich J; Armstrong M; Leslie JM; Weikel CS Am J Med; 1992 Aug; 93(2):163-70. PubMed ID: 1497012 [TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus infection in children. Hoernle EH; Reid TE Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. DiRienzo AG; van Der Horst C; Finkelstein DM; Frame P; Bozzette SA; Tashima KT AIDS Res Hum Retroviruses; 2002 Jan; 18(2):89-94. PubMed ID: 11839141 [TBL] [Abstract][Full Text] [Related]
29. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection. Su YS; Lu JJ; Perng CL; Chang FY J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691 [TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial of short-term withdrawal of i.v. immunoglobulin therapy for selected children with human immunodeficiency virus infection. Grisaru-Soen G; Lau W; Arneson C; Louch D; Bitnun A; Stephens D; Read SE; King SM Pediatr Int; 2007 Dec; 49(6):972-7. PubMed ID: 18045306 [TBL] [Abstract][Full Text] [Related]
31. A case of pneumocystis pneumonia after cessation of secondary prophylaxis. Quah SP; McBride M Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102 [TBL] [Abstract][Full Text] [Related]
33. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Chintu C; Bhat GJ; Walker AS; Mulenga V; Sinyinza F; Lishimpi K; Farrelly L; Kaganson N; Zumla A; Gillespie SH; Nunn AJ; Gibb DM; Lancet; 2004 Nov 20-26; 364(9448):1865-71. PubMed ID: 15555666 [TBL] [Abstract][Full Text] [Related]
34. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing? Miller RF Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633 [No Abstract] [Full Text] [Related]
35. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887 [TBL] [Abstract][Full Text] [Related]
36. CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. European Collaborative Study Group. BMJ; 1994 Feb; 308(6926):437-40. PubMed ID: 7907246 [TBL] [Abstract][Full Text] [Related]